Company Profile (AI Text)
Name: Imago Rehab
Canonical URL: https://wefunder.com/imago
Updated at: 2026-06-24T05:01:30Z

Tagline: AI & robotics for the $210B rehab industry

Key claims:
- Total raised on Wefunder: 127625 | citation: https://wefunder.com/imago#claim-total-raised
- Total investors: 147 | citation: https://wefunder.com/imago#claim-total-investors

Verified facts:
- Total raised on Wefunder: 127625 | observed_at: 2026-06-24T05:01:30Z | expires_at: 2026-06-25T05:01:30Z
- Total investors: 147 | observed_at: 2026-06-24T05:01:30Z | expires_at: 2026-06-25T05:01:30Z

Computed metrics:
- total_amount_raised: 127625
- total_investors: 147
- team_size: 5
- featured_investor_count: 2
- faq_count: 5
- recent_post_count: 5

Quick facts:
- Backed by AARP’s AgeTech Collaborative & leading VCs Safar Partners & Cybernetix Ventures | citation: https://wefunder.com/imago#claim-fact-1
- 5X better recovery results than traditional, in-clinic rehab | citation: https://wefunder.com/imago#claim-fact-2
- Insurance coverage via 23 top insurers including Medicare, United Healthcare, Humana & Anthem | citation: https://wefunder.com/imago#claim-fact-3
- 3 patents awarded for the Imago Glove, with 1 additional patent pending | citation: https://wefunder.com/imago#claim-fact-4
- World-class team from Harvard University, MIT, Humana, CVS/Aetna, Anthem & Intel | citation: https://wefunder.com/imago#claim-fact-5
- CO-Principal Investigator with Harvard University and Mass General Hospital on a $5M NSF grant. | citation: https://wefunder.com/imago#claim-fact-6
- Forecasting $46.8M in revenue by 2028 (not guaranteed) | citation: https://wefunder.com/imago#claim-fact-7
- Massive $210B neurological and cardiovascular rehab market | citation: https://wefunder.com/imago#claim-fact-8

FAQ:
- Q: Hello Imago Team, I’m Zac Stahlhut with D3VC. We specialize in investment crowdfunding and are keenly interested in your innovative approach to rehabilitation. With your ambitious goals for rapid expansion and technology enhancements, I’d like to get a clearer picture of your ...
  A: Zac, thanks for these great questions. We have some partnerships that just deployed in 4Q24, and they are now activating with patient volumes in 1Q25 setting 2025 up for an exciting growth year. In addition to our glove, we are collaborating with Harvard on a shoulder device, the R&D is funded by the National Science Foundation grant. So Imago is an ecosystem platform leveraging AI and soft wearable robotic devices with a solutions roadmap to address patient needs in a clinically comprehe...
- Q: Hi team, I have a background in physical therapy and this is very interesting technology. I'd love to learn a bit more about your business model. How would you describe your go-to-market approach? How will Imago charge it's clinical partners and distributors of it's technology...
  A: Imago Rehab is an outpatient clinical practice, so we submit claims to Medicare part B and Commercial Insurance for OT, PT, and Speech Therapy. Imago Rehab is supporting Harvard on the development of advanced sensors and a shoulder soft wearable robotic device funded by the National Science Foundation grant. Our glove is published in a peer-reviewed journal, wearable technologies: URL link here: https://www.cambridge.org/core/journals/wearable-technologies/article/combining-soft-robotics-and-...
- Q: Hello Chris, thank you for your detailed response. Your partnerships and recent progress are impressive, and it’s clear Imago is addressing a critical market need. I wanted to follow up with a question regarding your patents—specifically, what aspects of the technology or appl...
  A: Followed up via email to schedule time to discuss, we are issuing a press release today or Monday on our third patent being granted. Will update WeFunder investors with that news once we have the PR out.
- Q: Looks like you are 'oversubscribed', which according to terms eliminates the understanding of the shares distributed per dollar invested. I'd need that spelled out in certain terms in order to invest. Here is the language used for valuation of investment, "If the Offering is o...
  A: Kyle, thanks for your question, the platform establishes goals which we just recently achieved due to strong investor interest, but still allows for the opportunity to invest as the round still has additional room. We will reset the goal higher. This does not prohibit you from investing. you can still do so.
- Q: Hey Chris, Many questions, thanks in advance! Patents 1. Can you comment on what your patents cover exactly and if they are utility patents? 2. It appears you license them from Harvard and the company does not own them. Under what (if any) conditions could you lose access to t...
  A: David, thank you for these questions. there's a lot here, and I'd be happy to hop on a 30min zoom with you to help further answer. Yes, our neuro rehab care model is broader than stroke and can support neuro conditions such as Traumatic Brain Injury, Multiple Sclerosis, and Parkinsons. Like any good product organization, we use voice-of-customer to inform solution design. Our first voice-of-customer is the patient, our second is the physician/hospital system provider partner. Listening to our...

Recent posts:
- Imago Rehab Investor Update - February 2026 (2026-03-10T22:21:15Z) https://wefunder.com/feed/273753
- Imago Rehab Investor Update - January 2026 (2026-02-16T20:42:13Z) https://wefunder.com/feed/260050
- Imago Rehab Investor Update – November 2025 (2025-12-07T18:36:18Z) https://wefunder.com/feed/228456
- ⌛Last Chance to Invest in HCO: Community Round Closes Today (2025-09-28T16:02:17Z) https://wefunder.com/feed/193503
- 🚨Big News: HCO Acquires Majority Stake in Imago Rehab 🚨 (2025-09-09T19:24:45Z) https://wefunder.com/feed/185549